Whitehawk Therapeutics Inc ( WHWK) - Key Metrics
WHWK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.20 | -$0.18 | -$0.18 |
| 2026Q1 | $0 | -$0.32 | -$0.32 | -$0.32 |
| 2025Q4 | $0 | -$0.34 | -$0.25 | -$0.25 |
| 2025Q3 | $0 | -$0.26 | -$0.23 | -$0.23 |
| 2025Q2 | $0 | -$0.76 | -$0.77 | -$0.77 |
WHWK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.73 |
| 2026Q1 | 0% | -2.70 |
| 2025Q4 | 0% | -1.78 |
| 2025Q3 | 0% | -1.83 |
| 2025Q2 | 0% | -0.62 |
WHWK
Price: $4.69
52 week price:
Earnings Per Share: -1.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 268.5 million